We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > FSD-201

News List

FSD Receives FDA Approval to Design Trial for COVID-19 Treatment americanpharmaceuticalreview
June 15, 2020
FSD Pharma announced the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application (IND) for the use of FSD-201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.
FSD Pharma gets FDA nod to design Covid-19 trial with ultramicronised PEA pharmaceutical-business-review
June 05, 2020
FSD Pharma has secured approval from the US Food and Drug Administration (FDA) to design a phase 2a clinical trial to evaluate the efficacy of FSD-201 ...
FSD Pharma Gets Go Ahead for Phase IIa COVID-19 Trial contractpharma
June 04, 2020
To evaluate FSD-201 to treat COVID-19; anti-inflammatory properties aim to avoid the cytokine storm.